DONALD YEE to Antibodies, Monoclonal
This is a "connection" page, showing publications DONALD YEE has written about Antibodies, Monoclonal.
Connection Strength
0.037
-
Mosunetuzumab plus Pola-CHP compared with Pola-R-CHP in previously untreated DLBCL: final results from a phase 2 study. Blood Adv. 2025 May 27; 9(10):2461-2472.
Score: 0.037